Targeted protein degradation in hematologic malignancies: latest updates from the 2023 ASH annual meeting
G Zhong, R Kong, S Feng, C Wang, Q Hao… - Journal of Hematology & …, 2024 - Springer
Protein degraders, emerging as a novel class of therapeutic agents, have gained
widespread attention due to their advantages. They have several advantages over …
widespread attention due to their advantages. They have several advantages over …